• Discovery of Post-Vaccination Syndrome (PVS): Yale University researchers identified a rare syndrome linked to mRNA COVID-19 vaccines, characterized by symptoms such as brain fog, dizziness, tinnitus, and exercise intolerance.
• Biological Markers and Epstein-Barr Reactivation: The study found significant biological changes in PVS patients, including differences in immune cells and the presence of coronavirus proteins in their blood. Notably, the vaccine appeared to reactivate the Epstein-Barr virus, leading to a range of flu-like symptoms and nerve issues.
• Link to Long COVID: The research also revealed a potential connection between mRNA vaccines, Epstein-Barr reactivation, and post-vaccination symptoms, similar to those observed in long COVID patients. Both groups showed signs of Epstein-Barr reactivation, suggesting a possible shared underlying mechanism.
• Next Steps and Implications: The study’s findings, while preliminary, highlight the need for further research to understand the prevalence of PVS and identify those at risk. This work is crucial for developing better diagnostic tools and treatments, as well as addressing the concerns of vaccine recipients experiencing rare and severe side effects.

Clot Shot Lobotomy Syndrome, a.k.a. “Post Vaccination Syndrome,” is sweeping the nation, and researchers at Yale University are uncovering what natural health advocates warned the world about right from the beginning of the insidious Plandemic.

In a groundbreaking study, researchers from Yale University have uncovered a rare and alarming syndrome linked to the nanoparticle, spike prion, gene-mutating mRNA Covid vaccines. The condition, dubbed “post-vaccination syndrome” (PVS), has been found to cause a range of troubling symptoms, including brain fog, dizziness, tinnitus, and exercise intolerance.

The study, led by immunologist Dr. Akiko Iwasaki, collected blood samples from 42 people experiencing PVS and 22 people without it. The results reveal significant biological changes in those affected, including differences in immune cells and the presence of coronavirus proteins in their blood, even years after vaccination.

One of the most concerning findings is that the vaccine appears to reawaken a dormant virus called Epstein-Barr, which can cause flu-like symptoms, swollen lymph nodes, and nerve issues. This virus is common among adults, affecting more than nine in ten people at some point in their lives. Once it’s active, Epstein-Barr can remain dormant but can be reactivated when the immune system is weakened.

Dr. Iwasaki emphasized that the study is still in its early stages, and more research is needed to fully understand the syndrome. However, she expressed hope that these findings could eventually lead to better diagnostic tools and treatments for PVS.

Michelle Utter, a mother from Florida, shared her personal experience with PVS. After receiving the vaccine in 2021 to visit her military sons, she suddenly felt like she was “on fire inside” and could barely stand long enough to cook dinner. Her former athleticism was gone, and she found herself crawling on the floor.

Significant biological changes in the body and brain of the mRNA injected sheeple now recognized by leading researchers at Yale

The mRNA vaccines, made by Moderna and Pfizer, may have permanently damaged tens of millions of lives globally, including 3 million in the US. These new findings highlight the need for a more comprehensive understanding of their long-term effects.

Dr. Iwasaki’s team also analyzed the blood of 134 people with long Covid and 134 healthy vaccine recipients. Both groups showed signs of Epstein-Barr reactivation, indicating a potential link between the vaccine, Epstein-Barr, and post-vaccination symptoms. While the study’s results are still preliminary, the implications are significant. The fragmented nature of the U.S. healthcare system has made it challenging to identify rare side effects, and larger studies have struggled to separate vaccine-related symptoms from unrelated illnesses.

The next phase of the research will focus on determining the prevalence of PVS and identifying those most at risk. This work is crucial for understanding the full impact of the mRNA vaccines and ensuring that healthcare providers can better support patients experiencing these symptoms. As the severe damage done by mRNA jabs get uncovered, studies like this one remind us of the importance of ongoing research and the need to address the mass suffering of vaccine recipients. While he benefits of the vaccines are highly questionable, the potential for rare and severe side effects also cannot be ignored.

For those affected by PVS, the findings offer a glimmer of hope that they are not alone and that researchers are working to understand their condition. As Dr. Iwasaki said, “This work is still in its early stages, but it’s the first kind of glimpse at what may be going on within these people.”

The study highlights the complexities of medical research and the ongoing need to balance public health benefits with individual patient concerns. As we continue to navigate the challenges posed by the pandemic, studies like this one remind us that there is still much to learn and understand about the long-term effects of the vaccines. Bookmark plague.info to your favorite independent websites for updates on new gain-of-function viruses the CDC and WHO release into the “wild.” #DirtyVaccines

Sources for this article include:

TheGatewayPundit.com

Pandemic.news

NaturalNews.com